Tigress Financial Adjusts Price Target on Pershing Square to $54 From $41
Tigress Financial has updated its price target for Pershing Square Inc., raising it from $41 to $54 while maintaining a Neutral rating.
Stocks · News reference
Crude Oil Edges Higher; Citigroup Earnings Top Views
U.S. stocks edged lower; Citi beat Q3 estimates. Bumble and BIO-key surged, while Pershing Square, Cipher Digital and Syndax fell.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Pershing Square Holdings Confirms Fourth Quarter 2026 Dividend
Pershing Square Holdings has announced a quarterly dividend of $0.1837 per public share for the fourth quarter of 2026.
Bumble Inc. Reports Third-Quarter 2026 Financial Results
Bumble Inc. reported a decline in third-quarter 2026 revenue and net income, citing a decrease in paying users as a primary factor.
Fermi Inc. Discloses Shareholder Voting Dispute Following 2026 Annual Meeting
Fermi Inc. reported a dispute regarding the enforcement of a Director Nomination Agreement (DNA) during its 2026 Annual Meeting, alleging that certain investors failed to vote as contractually obligated.
Nebius Stock: The Bull Case, the Bear Case, and My Call Before Nov. 12
Nebius Group stock has fallen 47% from its June peak to around $152. The bull case rests on management's target of $7-9 billion annualized run-rate revenue by year-end 2026 (up from $3 billion in June), with the company demonstrating strong growth momentum. However, the bear case highlights massive capital expenditure needs ($20-25 billion in 2026) requiring significant external funding, customer concentration risk (3 customers = 59% of revenue), and reliance on share dilution and debt. The analyst recommends waiting for Q3 results on Nov. 12 to assess if the company remains on track for its targets before making an investment decision.
Cipher and BIO-key Integrate Technology to Expand Identity Security
Cipher has integrated BIO-key's identity security technologies into its cybersecurity portfolio to enhance enterprise identity and access management.